HBEGF

HBEGF Molekülinformation

Englischer Name	Heparin-binding EGF-like growth factor	Anzahl der inverkehr gebrachten Arzneimittel	0
Anzahl der klinischen Arzneimittel	0	Target-Alias	DTS，DTR，HB-EGF，DT-R，Diphtheria toxin receptor，HBEGF，Heparin Binding EGF Like Growth Factor，Diphtheria Toxin Receptor (Heparin-Binding Epidermal Growth Factor-Like Growth Factor)，Heparin-Binding Epidermal Growth Factor，HEGFL，Proheparin-Binding EGF-Like Growth Factor，Heparin-Binding EGF-Like Growth Factor，DTSF，Diphtheria Toxin Receptor (Heparin-Binding EGF-Like Growth Factor)
Höchste Forschungs- und Entwicklungsphase	Discontinued

Englischer Name	Heparin-binding EGF-like growth factor
Target-Alias	DTS，DTR，HB-EGF，DT-R，Diphtheria toxin receptor，HBEGF，Heparin Binding EGF Like Growth Factor，Diphtheria Toxin Receptor (Heparin-Binding Epidermal Growth Factor-Like Growth Factor)，Heparin-Binding Epidermal Growth Factor，HEGFL，Proheparin-Binding EGF-Like Growth Factor，Heparin-Binding EGF-Like Growth Factor，DTSF，Diphtheria Toxin Receptor (Heparin-Binding EGF-Like Growth Factor)
Anzahl der inverkehr gebrachten Arzneimittel	0
Anzahl der klinischen Arzneimittel	0
Höchste Forschungs- und Entwicklungsphase	Discontinued

Produktanfrage

HBEGF Molekülhintergrund

Heparin-binding epidermal growth factor (EGF)-like growth factor (HBEGF) is a ligand for the EGF receptor (EGFR) and a critical molecular component to a number of normal physiological processes including but not limited to tissue injury and wound healing, reproduction, angiogenesis and recently, adipogenesis. Misexpression of HB-EGF is linked to tumor formation and cancer including hepatocellular, pancreatic, gastric, breast, colon and melanoma, gliomas and glioblastomas.